Oncology Brothers

GU Oncology Now

Andrea Apolo, MD, Chief of Bladder Cancer &ndash; Genitourinary Malignancy at the National Cancer Institute, shares her approach to treating bladder cancer as the field continues to evolve following the outcomes of phase III trials.Review the algorithm discussed.<img loading="lazy" decoding="async" class="aligncenter wp-image-5060 size-large" src="https://mumcdnstorage.blob.core.windows.net/guonc/2023/01/Bladder-Cancer-1024x565.jpg" alt="Bladder cancer treatment algorithm" width="1024" height="565">

Bladder Cancer Treatment Algorithm, According to Dr. Andrea Apolo

Andrea Apolo, MD, Chief of Bladder Cancer - Genitourinary Malignancy at the NCI, discusses bladder cancer treatment.

Bladder Cell Cancer Algorithm Discussion with Andrea Apolo

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

The Uromigos

Uromigos Live 2024

AUC3

Localized

mHSPC/mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe